1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Polyenes 1.2.3 Echinocandins 1.2.4 Azoles 1.2.5 Allylamines 1.2.6 Other Drug types 1.3 Market by Application 1.3.1 Global Antifungal infection Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Powders 1.3.3 Pastes 1.3.4 Ointments 1.3.5 Drugs 1.3.6 Other Applications 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antifungal infection Therapeutics Market Perspective (2016-2027) 2.2 Antifungal infection Therapeutics Growth Trends by Regions 2.2.1 Antifungal infection Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Antifungal infection Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Antifungal infection Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Antifungal infection Therapeutics Industry Dynamic 2.3.1 Antifungal infection Therapeutics Market Trends 2.3.2 Antifungal infection Therapeutics Market Drivers 2.3.3 Antifungal infection Therapeutics Market Challenges 2.3.4 Antifungal infection Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antifungal infection Therapeutics Players by Revenue 3.1.1 Global Top Antifungal infection Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Antifungal infection Therapeutics Revenue 3.4 Global Antifungal infection Therapeutics Market Concentration Ratio 3.4.1 Global Antifungal infection Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antifungal infection Therapeutics Revenue in 2020 3.5 Antifungal infection Therapeutics Key Players Head office and Area Served 3.6 Key Players Antifungal infection Therapeutics Product Solution and Service 3.7 Date of Enter into Antifungal infection Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antifungal infection Therapeutics Breakdown Data by Type 4.1 Global Antifungal infection Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Antifungal infection Therapeutics Forecasted Market Size by Type (2022-2027) 5 Antifungal infection Therapeutics Breakdown Data by Application 5.1 Global Antifungal infection Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Antifungal infection Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Antifungal infection Therapeutics Market Size (2016-2027) 6.2 North America Antifungal infection Therapeutics Market Size by Type 6.2.1 North America Antifungal infection Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Antifungal infection Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Antifungal infection Therapeutics Market Size by Type (2016-2027) 6.3 North America Antifungal infection Therapeutics Market Size by Application 6.3.1 North America Antifungal infection Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Antifungal infection Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Antifungal infection Therapeutics Market Size by Application (2016-2027) 6.4 North America Antifungal infection Therapeutics Market Size by Country 6.4.1 North America Antifungal infection Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Antifungal infection Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Antifungal infection Therapeutics Market Size (2016-2027) 7.2 Europe Antifungal infection Therapeutics Market Size by Type 7.2.1 Europe Antifungal infection Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Antifungal infection Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Antifungal infection Therapeutics Market Size by Type (2016-2027) 7.3 Europe Antifungal infection Therapeutics Market Size by Application 7.3.1 Europe Antifungal infection Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Antifungal infection Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Antifungal infection Therapeutics Market Size by Application (2016-2027) 7.4 Europe Antifungal infection Therapeutics Market Size by Country 7.4.1 Europe Antifungal infection Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Antifungal infection Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Antifungal infection Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Type 8.2.1 Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Application 8.3.1 Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Antifungal infection Therapeutics Market Size by Region 8.4.1 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Antifungal infection Therapeutics Market Size (2016-2027) 9.2 Latin America Antifungal infection Therapeutics Market Size by Type 9.2.1 Latin America Antifungal infection Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Antifungal infection Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Antifungal infection Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Antifungal infection Therapeutics Market Size by Application 9.3.1 Latin America Antifungal infection Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Antifungal infection Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Antifungal infection Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Antifungal infection Therapeutics Market Size by Country 9.4.1 Latin America Antifungal infection Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Antifungal infection Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antifungal infection Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Type 10.2.1 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Application 10.3.1 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Antifungal infection Therapeutics Market Size by Country 10.4.1 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Scynexis 11.1.1 Scynexis Company Details 11.1.2 Scynexis Business Overview 11.1.3 Scynexis Antifungal infection Therapeutics Introduction 11.1.4 Scynexis Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.1.5 Scynexis Recent Development 11.2 Sanofi-Aventis 11.2.1 Sanofi-Aventis Company Details 11.2.2 Sanofi-Aventis Business Overview 11.2.3 Sanofi-Aventis Antifungal infection Therapeutics Introduction 11.2.4 Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.2.5 Sanofi-Aventis Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Antifungal infection Therapeutics Introduction 11.3.4 Pfizer Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Antifungal infection Therapeutics Introduction 11.4.4 Novartis Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Merck & Co 11.5.1 Merck & Co Company Details 11.5.2 Merck & Co Business Overview 11.5.3 Merck & Co Antifungal infection Therapeutics Introduction 11.5.4 Merck & Co Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.5.5 Merck & Co Recent Development 11.6 Kramer Laboratories 11.6.1 Kramer Laboratories Company Details 11.6.2 Kramer Laboratories Business Overview 11.6.3 Kramer Laboratories Antifungal infection Therapeutics Introduction 11.6.4 Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.6.5 Kramer Laboratories Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Antifungal infection Therapeutics Introduction 11.7.4 Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.7.5 Johnson & Johnson Recent Development 11.8 ID Sigma-Aldrich Corporation 11.8.1 ID Sigma-Aldrich Corporation Company Details 11.8.2 ID Sigma-Aldrich Corporation Business Overview 11.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Introduction 11.8.4 ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.8.5 ID Sigma-Aldrich Corporation Recent Development 11.9 Glenmark Pharmaceuticals 11.9.1 Glenmark Pharmaceuticals Company Details 11.9.2 Glenmark Pharmaceuticals Business Overview 11.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Introduction 11.9.4 Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.9.5 Glenmark Pharmaceuticals Recent Development 11.10 Glaxosmithkline 11.10.1 Glaxosmithkline Company Details 11.10.2 Glaxosmithkline Business Overview 11.10.3 Glaxosmithkline Antifungal infection Therapeutics Introduction 11.10.4 Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.10.5 Glaxosmithkline Recent Development 11.11 Enzon Pharmaceuticals 11.11.1 Enzon Pharmaceuticals Company Details 11.11.2 Enzon Pharmaceuticals Business Overview 11.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Introduction 11.11.4 Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.11.5 Enzon Pharmaceuticals Recent Development 11.12 Bayer Healthcare 11.12.1 Bayer Healthcare Company Details 11.12.2 Bayer Healthcare Business Overview 11.12.3 Bayer Healthcare Antifungal infection Therapeutics Introduction 11.12.4 Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.12.5 Bayer Healthcare Recent Development 11.13 Astellas Pharma 11.13.1 Astellas Pharma Company Details 11.13.2 Astellas Pharma Business Overview 11.13.3 Astellas Pharma Antifungal infection Therapeutics Introduction 11.13.4 Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.13.5 Astellas Pharma Recent Development 11.14 Asperqillus 11.14.1 Asperqillus Company Details 11.14.2 Asperqillus Business Overview 11.14.3 Asperqillus Antifungal infection Therapeutics Introduction 11.14.4 Asperqillus Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.14.5 Asperqillus Recent Development 11.15 Alternaria 11.15.1 Alternaria Company Details 11.15.2 Alternaria Business Overview 11.15.3 Alternaria Antifungal infection Therapeutics Introduction 11.15.4 Alternaria Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.15.5 Alternaria Recent Development 11.16 Abbott Laboratories 11.16.1 Abbott Laboratories Company Details 11.16.2 Abbott Laboratories Business Overview 11.16.3 Abbott Laboratories Antifungal infection Therapeutics Introduction 11.16.4 Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021) 11.16.5 Abbott Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Antifungal infection Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Polyenes Table 3. Key Players of Echinocandins Table 4. Key Players of Azoles Table 5. Key Players of Allylamines Table 6. Key Players of Other Drug types Table 7. Global Antifungal infection Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Antifungal infection Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Antifungal infection Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Antifungal infection Therapeutics Market Share by Regions (2016-2021) Table 11. Global Antifungal infection Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Antifungal infection Therapeutics Market Share by Regions (2022-2027) Table 13. Antifungal infection Therapeutics Market Trends Table 14. Antifungal infection Therapeutics Market Drivers Table 15. Antifungal infection Therapeutics Market Challenges Table 16. Antifungal infection Therapeutics Market Restraints Table 17. Global Antifungal infection Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Antifungal infection Therapeutics Market Share by Players (2016-2021) Table 19. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifungal infection Therapeutics as of 2020) Table 20. Ranking of Global Top Antifungal infection Therapeutics Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Antifungal infection Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Antifungal infection Therapeutics Product Solution and Service Table 24. Date of Enter into Antifungal infection Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 27. Global Antifungal infection Therapeutics Revenue Market Share by Type (2016-2021) Table 28. Global Antifungal infection Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Antifungal infection Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Antifungal infection Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Antifungal infection Therapeutics Revenue Market Share by Application (2016-2021) Table 32. Global Antifungal infection Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Antifungal infection Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 35. North America Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 37. North America Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 64. Scynexis Company Details Table 65. Scynexis Business Overview Table 66. Scynexis Antifungal infection Therapeutics Product Table 67. Scynexis Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 68. Scynexis Recent Development Table 69. Sanofi-Aventis Company Details Table 70. Sanofi-Aventis Business Overview Table 71. Sanofi-Aventis Antifungal infection Therapeutics Product Table 72. Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 73. Sanofi-Aventis Recent Development Table 74. Pfizer Company Details Table 75. Pfizer Business Overview Table 76. Pfizer Antifungal infection Therapeutics Product Table 77. Pfizer Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 78. Pfizer Recent Development Table 79. Novartis Company Details Table 80. Novartis Business Overview Table 81. Novartis Antifungal infection Therapeutics Product Table 82. Novartis Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 83. Novartis Recent Development Table 84. Merck & Co Company Details Table 85. Merck & Co Business Overview Table 86. Merck & Co Antifungal infection Therapeutics Product Table 87. Merck & Co Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 88. Merck & Co Recent Development Table 89. Kramer Laboratories Company Details Table 90. Kramer Laboratories Business Overview Table 91. Kramer Laboratories Antifungal infection Therapeutics Product Table 92. Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 93. Kramer Laboratories Recent Development Table 94. Johnson & Johnson Company Details Table 95. Johnson & Johnson Business Overview Table 96. Johnson & Johnson Antifungal infection Therapeutics Product Table 97. Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 98. Johnson & Johnson Recent Development Table 99. ID Sigma-Aldrich Corporation Company Details Table 100. ID Sigma-Aldrich Corporation Business Overview Table 101. ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 102. ID Sigma-Aldrich Corporation Recent Development Table 103. Glenmark Pharmaceuticals Company Details Table 104. Glenmark Pharmaceuticals Business Overview Table 105. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product Table 106. Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 107. Glenmark Pharmaceuticals Recent Development Table 108. Glaxosmithkline Company Details Table 109. Glaxosmithkline Business Overview Table 110. Glaxosmithkline Antifungal infection Therapeutics Product Table 111. Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 112. Glaxosmithkline Recent Development Table 113. Enzon Pharmaceuticals Company Details Table 114. Enzon Pharmaceuticals Business Overview Table 115. Enzon Pharmaceuticals Antifungal infection Therapeutics Product Table 116. Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 117. Enzon Pharmaceuticals Recent Development Table 118. Bayer Healthcare Company Details Table 119. Bayer Healthcare Business Overview Table 120. Bayer Healthcare Antifungal infection Therapeutics Product Table 121. Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 122. Bayer Healthcare Recent Development Table 123. Astellas Pharma Company Details Table 124. Astellas Pharma Business Overview Table 125. Astellas Pharma Antifungal infection Therapeutics Product Table 126. Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 127. Astellas Pharma Recent Development Table 128. Asperqillus Company Details Table 129. Asperqillus Business Overview Table 130. Asperqillus Antifungal infection Therapeutics Product Table 131. Asperqillus Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 132. Asperqillus Recent Development Table 133. Alternaria Company Details Table 134. Alternaria Business Overview Table 135. Alternaria Antifungal infection Therapeutics Product Table 136. Alternaria Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 137. Alternaria Recent Development Table 138. Abbott Laboratories Company Details Table 139. Abbott Laboratories Business Overview Table 140. Abbott Laboratories Antifungal infection Therapeutics Product Table 141. Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million) Table 142. Abbott Laboratories Recent Development Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Global Antifungal infection Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Polyenes Features Figure 3. Echinocandins Features Figure 4. Azoles Features Figure 5. Allylamines Features Figure 6. Other Drug types Features Figure 7. Global Antifungal infection Therapeutics Market Share by Application: 2020 VS 2027 Figure 8. Powders Case Studies Figure 9. Pastes Case Studies Figure 10. Ointments Case Studies Figure 11. Drugs Case Studies Figure 12. Other Applications Case Studies Figure 13. Antifungal infection Therapeutics Report Years Considered Figure 14. Global Antifungal infection Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Antifungal infection Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Antifungal infection Therapeutics Market Share by Regions: 2020 VS 2027 Figure 17. Global Antifungal infection Therapeutics Market Share by Regions (2022-2027) Figure 18. Global Antifungal infection Therapeutics Market Share by Players in 2020 Figure 19. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifungal infection Therapeutics as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Antifungal infection Therapeutics Revenue in 2020 Figure 21. Global Antifungal infection Therapeutics Revenue Market Share by Type (2016-2021) Figure 22. Global Antifungal infection Therapeutics Revenue Market Share by Type (2022-2027) Figure 23. North America Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Antifungal infection Therapeutics Market Share by Type (2016-2027) Figure 25. North America Antifungal infection Therapeutics Market Share by Application (2016-2027) Figure 26. North America Antifungal infection Therapeutics Market Share by Country (2016-2027) Figure 27. United States Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Antifungal infection Therapeutics Market Share by Type (2016-2027) Figure 31. Europe Antifungal infection Therapeutics Market Share by Application (2016-2027) Figure 32. Europe Antifungal infection Therapeutics Market Share by Country (2016-2027) Figure 33. Germany Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Antifungal infection Therapeutics Market Share by Type (2016-2027) Figure 41. Asia-Pacific Antifungal infection Therapeutics Market Share by Application (2016-2027) Figure 42. Asia-Pacific Antifungal infection Therapeutics Market Share by Region (2016-2027) Figure 43. China Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Antifungal infection Therapeutics Market Share by Type (2016-2027) Figure 51. Latin America Antifungal infection Therapeutics Market Share by Application (2016-2027) Figure 52. Latin America Antifungal infection Therapeutics Market Share by Country (2016-2027) Figure 53. Mexico Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Antifungal infection Therapeutics Market Share by Type (2016-2027) Figure 57. Middle East & Africa Antifungal infection Therapeutics Market Share by Application (2016-2027) Figure 58. Middle East & Africa Antifungal infection Therapeutics Market Share by Country (2016-2027) Figure 59. Turkey Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Scynexis Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 63. Sanofi-Aventis Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 66. Merck & Co Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 67. Kramer Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 68. Johnson & Johnson Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 69. ID Sigma-Aldrich Corporation Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 70. Glenmark Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 71. Glaxosmithkline Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 72. Enzon Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 73. Bayer Healthcare Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 74. Astellas Pharma Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 75. Asperqillus Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 76. Alternaria Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 77. Abbott Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Scynexis Sanofi-Aventis Pfizer Novartis Merck & Co Kramer Laboratories Johnson & Johnson ID Sigma-Aldrich Corporation Glenmark Pharmaceuticals Glaxosmithkline Enzon Pharmaceuticals Bayer Healthcare Astellas Pharma Asperqillus Alternaria Abbott Laboratories